Mexico Veterinary Ocular NSAIDs Market Size, by Product Classification (2024-2032)

An evolving competitive structure defined the Mexico Veterinary Ocular NSAIDs Market Size (***–***), where branded veterinary products showcased a clear lead, valued at USD ***.*** thousand in ***. The segment is estimated to continue its dominance through *** and beyond, maintaining the highest market share throughout the assessment period. By ***, branded veterinary products are projected to reach USD ***.*** thousand, remaining the top-performing category, while off-label human ocular formulations are projected to remain the lowest across all years, starting at USD *** thousand in ***. Generic veterinary products and compounded drugs held intermediate positions, indicating moderate yet consistent growth in demand. The overall dominance of branded veterinary NSAIDs in Mexico’s market is attributed to superior clinical outcomes, strong veterinarian preference, and established brand reliability. Additionally, the increasing availability of advanced formulations and quality assurance...